Sulzberger Gabrielle

Sulzberger Gabrielle is listed in filings as Director at Eli Lilly and Co. This profile follows SEC Form 4 activity through May 19, 2026, including 12 public disclosures. Recent filings connect the profile to Eli Lilly and Co (LLY), Mastercard Inc (MA), and Cerevel Therapeutics Holdings, Inc. (CERE). The current snapshot covers public activity from Aug 5, 2024 to May 19, 2026. Reported amounts are shown as $5.0K to $2.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.